Thompson Rahsaan (CIK 1788524) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-23). Recent activity: Sell ZVRA (34,557 shares), Buy ZVRA (66,667 shares), Sell ZVRA (1,794 shares), Buy ZVRA (11,333 shares), Sell ZVRA (4,080 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Sell | 34,557 | $438,304 |
| 2026-06-23 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Buy | 66,667 | $0 |
| 2026-05-13 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Sell | 1,794 | $20,272 |
| 2026-02-02 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Buy | 11,333 | $0 |
| 2026-02-02 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Sell | 4,080 | $36,026 |
| 2025-06-30 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Sell | 24,000 | $221,040 |
| 2025-06-24 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Chief Legal & Compliance | Buy | 66,666 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23